Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients - PubMed (original) (raw)
Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients
J C Lee et al. Eur J Cancer. 2000 Apr.
Abstract
Solid tumours require neovascularisation for growth and metastasis. Vascular endothelial growth factor (VEGF) has been shown to be an important regulator of tumour angiogenesis. To examine the relevance of VEGF in the neoplastic transformation of human colon, we analysed protein expression in a total 30 polyps and 145 colorectal carcinomas by immunohistochemistry. All adenoma specimens, regardless of histological differentiation, and normal colonic mucosa did not express VEGF. Amongst 90 patients with non-metastatic colorectal cancer, VEGF expression was observed in 43 (48%) cases, whilst 29 of the 55 patients (53%) with metastases expressed the angiogenic factor. Both the proportion and intensity of VEGF expression were positively associated with the progression of colon carcinogenesis. Tumours with the highest VEGF expression tended to correlate with patients' survival, although VEGF expression did not emerge as an independent risk factor in a multivariate analysis. After exclusion of the patients with distant metastases, both univariate and multivariate analysis did not indicate any prognostic value for the tissues with the highest VEGF expression. Our results suggest that VEGF may play a role in the progression of colon cancer, although evaluation of this angiogenic phenotype did not provide additional prognostic information compared with that obtained from Dukes' staging of the tumours.
Similar articles
- The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB. Hanrahan V, et al. J Pathol. 2003 Jun;200(2):183-94. doi: 10.1002/path.1339. J Pathol. 2003. PMID: 12754739 - Factors influencing tissue concentration of vascular endothelial growth factor in colorectal carcinoma.
Ono T, Miki C. Ono T, et al. Am J Gastroenterol. 2000 Apr;95(4):1062-7. doi: 10.1111/j.1572-0241.2000.01909.x. Am J Gastroenterol. 2000. PMID: 10763960 - Vascular endothelial growth factor and soft tissue sarcomas: tumor expression correlates with grade.
Chao C, Al-Saleem T, Brooks JJ, Rogatko A, Kraybill WG, Eisenberg B. Chao C, et al. Ann Surg Oncol. 2001 Apr;8(3):260-7. doi: 10.1007/s10434-001-0260-9. Ann Surg Oncol. 2001. PMID: 11314944 - Vascular endothelial growth factor (VEGF), a survival factor for tumour cells: implications for anti-angiogenic therapy.
Harmey JH, Bouchier-Hayes D. Harmey JH, et al. Bioessays. 2002 Mar;24(3):280-3. doi: 10.1002/bies.10043. Bioessays. 2002. PMID: 11891765 Review. - Prognostic value of angiogenesis in gastro-intestinal tumours.
Chung YS, Maeda K, Sowa M. Chung YS, et al. Eur J Cancer. 1996 Dec;32A(14):2501-5. doi: 10.1016/s0959-8049(96)00382-6. Eur J Cancer. 1996. PMID: 9059339 Review. No abstract available.
Cited by
- Elevated VEGF-A Levels in the Aqueous Humor of Patients With Primary Open Angle Glaucoma.
Dimtsas GS, Ieronymaki A, Chatzistefanou KI, Siasos G, Krassas A, Moschos MM. Dimtsas GS, et al. In Vivo. 2024 Jul-Aug;38(4):1875-1881. doi: 10.21873/invivo.13642. In Vivo. 2024. PMID: 38936903 Free PMC article. - Differences of vascular endothelial growth factor (VEGF) expression between liver and abdominal metastases from colon cancer. Implications for the treatment with VEGF inhibitors.
Cascinu S, Graziano F, Catalano V, Staccioli MP, Barni S, Giordani P, Rossi MC, Baldelli AM, Muretto P, Valenti A, Catalano G. Cascinu S, et al. Clin Exp Metastasis. 2000;18(8):651-5. doi: 10.1023/a:1013133224044. Clin Exp Metastasis. 2000. PMID: 11827068 - Predictive and prognostic markers in colorectal cancer.
Wilson PM, Ladner RD, Lenz HJ. Wilson PM, et al. Gastrointest Cancer Res. 2007 Nov;1(6):237-46. Gastrointest Cancer Res. 2007. PMID: 19262902 Free PMC article. - Lentivirus-mediated RNAi knockdown of VEGFA in RKO colorectal cancer cells decreases tumor formation and growth in vitro and in vivo.
Qiu JF, Zhang ZQ, Wang Y, You J. Qiu JF, et al. Int J Clin Exp Pathol. 2012;5(4):290-8. Epub 2011 Apr 30. Int J Clin Exp Pathol. 2012. PMID: 22670172 Free PMC article. - Association of -2549 insertion/deletion polymorphism of vascular endothelial growth factor with breast cancer in North Indian patients.
Kapahi R, Manjari M, Uppal MS, Singh NR, Sambyal V, Guleria K. Kapahi R, et al. Genet Test Mol Biomarkers. 2013 Mar;17(3):242-8. doi: 10.1089/gtmb.2012.0222. Epub 2013 Feb 7. Genet Test Mol Biomarkers. 2013. PMID: 23390884 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical